1. Home
  2. SNWV vs TRDA Comparison

SNWV vs TRDA Comparison

Compare SNWV & TRDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SNWV
  • TRDA
  • Stock Information
  • Founded
  • SNWV 2004
  • TRDA 2016
  • Country
  • SNWV United States
  • TRDA United States
  • Employees
  • SNWV N/A
  • TRDA N/A
  • Industry
  • SNWV
  • TRDA Biotechnology: Pharmaceutical Preparations
  • Sector
  • SNWV
  • TRDA Health Care
  • Exchange
  • SNWV NYSE
  • TRDA Nasdaq
  • Market Cap
  • SNWV 309.9M
  • TRDA 264.5M
  • IPO Year
  • SNWV N/A
  • TRDA 2021
  • Fundamental
  • Price
  • SNWV $36.24
  • TRDA $5.80
  • Analyst Decision
  • SNWV Strong Buy
  • TRDA Strong Buy
  • Analyst Count
  • SNWV 1
  • TRDA 3
  • Target Price
  • SNWV $49.00
  • TRDA $25.67
  • AVG Volume (30 Days)
  • SNWV 57.2K
  • TRDA 157.9K
  • Earning Date
  • SNWV 08-11-2025
  • TRDA 08-12-2025
  • Dividend Yield
  • SNWV N/A
  • TRDA N/A
  • EPS Growth
  • SNWV N/A
  • TRDA N/A
  • EPS
  • SNWV N/A
  • TRDA 0.61
  • Revenue
  • SNWV $36,190,000.00
  • TRDA $172,220,000.00
  • Revenue This Year
  • SNWV N/A
  • TRDA N/A
  • Revenue Next Year
  • SNWV N/A
  • TRDA N/A
  • P/E Ratio
  • SNWV N/A
  • TRDA $9.56
  • Revenue Growth
  • SNWV 61.50
  • TRDA 5.74
  • 52 Week Low
  • SNWV $5.21
  • TRDA $5.62
  • 52 Week High
  • SNWV $39.83
  • TRDA $21.79
  • Technical
  • Relative Strength Index (RSI)
  • SNWV N/A
  • TRDA 35.53
  • Support Level
  • SNWV N/A
  • TRDA $6.18
  • Resistance Level
  • SNWV N/A
  • TRDA $6.81
  • Average True Range (ATR)
  • SNWV 0.00
  • TRDA 0.36
  • MACD
  • SNWV 0.00
  • TRDA -0.01
  • Stochastic Oscillator
  • SNWV 0.00
  • TRDA 14.06

About SNWV SANUWAVE HEALTH INC

SANUWAVE Health Inc is an ultrasound and shock wave technology company using patented systems of noninvasive, high-energy, acoustic shock waves or low-intensity and non-contact ultrasound for regenerative medicine and other applications. The company's focus is regenerative medicine utilizing noninvasive, acoustic shock waves or ultrasound to produce a biological response resulting in the body healing itself through the repair and regeneration of tissue, musculoskeletal, and vascular structures. The company's two primary systems are UltraMIST and PACE. UltraMIST and PACE are the only two Food and Drug Administration (FDA) approved directed energy systems for wound healing.

About TRDA Entrada Therapeutics Inc.

Entrada Therapeutics Inc clinical-stage biopharmaceutical company aiming to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. The Company's Endosomal Escape Vehicle (EEV)-therapeutics are designed to enable the efficient delivery of a wide range of therapeutics into a variety of organs and tissues, resulting in an improved therapeutic index. Its pipeline includes solutions for Neuromuscular Disease, Beyond Neuromuscular, and Platform Expansion.

Share on Social Networks: